Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EssilorLuxottica Proxy Solicitation & Information Statement 2010

Mar 31, 2010

1298_iss_2010-03-31_de13aff5-5d99-4397-b209-2c43e8ec55eb.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Regulatory Information

Procedures for Requesting or Viewing Proxy Information for the Combined Ordinary and Extraordinary Annual Meeting on May 11, 2010

(Charenton-le-Pont, France – Marc 31, 2010 – 6:00 p.m.) – Shareholders are advised that the Combined Ordinary and Extraordinary Annual Meeting will be held on Tuesday, May 11, 2010 at 10:30 am at Centre de Conférences du Palais de la Bourse, Place de la Bourse, 75002 Paris.

The Notice of Meeting, published in the Bulletin des Annonces Légales Obligatoires on March 24, 2009, contains information on the agenda, the proposed resolutions and the procedures for attending and voting.

Proxy information may be viewed in the Shareholders section of the Essilor website at www.essilor.com : 2010 shareholders' meeting.

As provided for in articles R.225-88 and R.225-89 of the French Commercial Code, any shareholder may consult the proxy documents and information, as described in article R.225-83 of the Commercial Code, at Company headquarters (147 rue de Paris, 94220 Charenton-le-Pont, France) or request that such documents be sent to him or her, by writing to Société Générale, Service des Assemblées, 32 rue du Champ de Tir, BP 81236 – 44312 Nantes Cedex 3.

The world leader in ophthalmic optical products, Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its flagship brands are Varilux® , Crizal® , Essilor® , Definity® and Xperio™. Based in France, the company reported consolidated revenue of €3.2 billion in 2009, with 34,700 employees and operations in 100 countries.

For more information, please visit www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

Investor Relations and Financial Communications Phone: +33 (0)1 49 77 42 16 www.essilor.com